Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • abbreviated new drug...

    Tag: abbreviated new drug applications

    You Searched For "abbreviated new drug applications"
    Glenmark gets USFDA approval for Rythmol SR generic

    Glenmark gets USFDA approval for Rythmol SR generic

    Ruby Khatun Khatun13 Sept 2017 2:08 PM IST
    New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for the generic version of Rythmol SR capsules, an...
    Biocon aspiring for 1 billion dollar revenues by FY19

    Biocon aspiring for 1 billion dollar revenues by FY19

    Ruby Khatun Khatun11 Sept 2017 10:22 AM IST
    New Delhi: Biocon is betting big on small molecules and generic formulations, biosimilars, branded formulations and research services as it targets $1...
    Zydus Cadila gets USFDA nod to market HIV drug

    Zydus Cadila gets USFDA nod to market HIV drug

    Ruby Khatun Khatun10 Aug 2017 9:30 AM IST
    New Delhi: Drug firm Zydus Cadila on Tuesday said it has received the tentative approval from the US health regulator to market Abacavir and...
    Zydus Cadila gets USFDA nod to market alcohol abstinence drug

    Zydus Cadila gets USFDA nod to market alcohol abstinence drug

    Ruby Khatun Khatun29 May 2017 11:56 AM IST
    New Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market Acamprosate calcium delayed-release tablets used for...
    Glenmark gets USFDA nod for contraceptive tablets

    Glenmark gets USFDA nod for contraceptive tablets

    savita thakur thakur25 Feb 2016 1:13 PM IST
    New Delhi: Glenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl...
    Prev

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok